Evosep and Molecular You have announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling.
The collaboration combines Evosep’s liquid chromatography platform with Molecular You’s biomarker analysis and interpretation workflows. The companies aim to enable scalable, globally deployable solutions for early disease assessment and proactive health management.
Molecular You will integrate the Evosep Eno system into its proteomics workflow. The integration supports the company’s transition toward reproducible, CLIA-grade multi-omic testing and aims to ensure consistent performance across Molecular You’s international partner laboratory network.
Jim Kean, CEO of Molecular You, emphasized the role of reproducibility and global deployment in the collaboration: “Our mission is to help people protect their health through meaningful guidance and earlier insights into their health risk, built upon advanced multi-omic analysis. By integrating Evosep’s proven, high-throughput LC platform, we can ensure that our workflows are reproducible, scalable, and ready for global deployment across our partner lab network. This is a key step toward making early disease detection accessible at scale.”
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
The partnership addresses a gap in multi-omics: the need for standardized, scalable front-end workflows that match the sophistication of modern data analytics.
Molecular You’s platform combines proteomics and metabolomics measurements from a single blood sample. It covers more than 190 biomarkers across multiple biological systems and disease pathways and translates the data into actionable health insights and personalized recommendations.
Through the collaboration, Evosep’s high-throughput LC platform will connect with Molecular You’s multi-omic analytics and interpretation engine. The companies aim to deliver a standardized workflow from sample preparation to clinical insight, enabling consistent, system-level health analysis at scale.
Morten Bern, CEO of Evosep, highlighted standardization as a foundation for routine multi-omic testing: “Standardization is the foundation for bringing proteomics and multi-omics into routine use. Partnering with Molecular You, we are extending Evosep Proteomics into a complete, scalable solution that standardizes workflows from sample to separation and connects reliable front-end processes with advanced data interpretation. Together, we are enabling global deployment of multi-omic testing with the consistency and quality required for actionable insights.”
Evosep aims to improve quality of life and patient care by innovating protein-based clinical diagnostics. The company develops technologies and solutions designed to make sample separation 100 times more robust and 10 times faster than current alternatives. The Evosep Eno is for General Laboratory Use.
Molecular You measures more than 200 biomarkers with a single blood test using advanced proteomics and metabolomics. Its AI-powered platform delivers personalized assessments, insights, and actionable recommendations across more than 25 health areas.
This article is based on a press release issued by Evosep.
